4 min read
How Confounding Forces Impact Medical Device Development
Bob Bouthillier Director, Electrical Engineering, Veranex We live in a time where we have easy access to biometrics that help both...
Traditional CROs fragment device development with costly hand-offs and learning curves. Veranex unites the essential disciplines for medical device & diagnostic development under one roof from sketch to evidence-generation to market launch.
All connected. All aligned. All accelerating your path to market—delivering breakthrough devices and diagnostics that improve patient lives sooner.
Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.
Purpose-built solutions. Proven results. User & Patient-centered innovation.
Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity. Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.
We are the Innovation CRO.
Legacy of excellence. Proven execution. Patient impact accelerated.
1 min read
Gary Keeler : Dec 9, 2020 11:22:38 AM
Alcon, a global leader in eye care, collaborated with Veranex (formerly Boston Healthcare Associates) to conduct a Time-and-Motion Study to support the value communication of its novel swept-source optical coherence tomography biometer, ARGOS®. In addition to superior acquisition rate compared to standard biometers, ARGOS features integration capabilities with Alcon’s VERION® image-guidance and the Alcon Cataract Refractive Suite inside the operating room (OR). Veranex collected real-world observational data with Principal Investigator Dr. Lawrence Woodard and was able to demonstrate substantial time efficiencies using ARGOS.
Veranex’s observational research team is made up of experienced individuals specializing in outcomes research including study design, patient identification, data analysis, and publication expertise. Veranex planned and executed the Time-and-Motion Study and developed a customer-friendly value model, demonstrating the potential time savings to cataract surgery sites from the adoption of ARGOS. For this Time-and-Motion Study, Veranex collected time measurements for 22 cataract patients in the reception area, clinic, LenSx room and OR. The model demonstrated that for 1,000 patients, ARGOS can save up to 74-hours and 24 minutes (~4.5 mins/patient). Alcon will utilize the results from the study and the value model as a sales aid, enabling practices to toggle between different practice-related scenarios and evaluate the time savings that can be achieved at their practice by adopting ARGOS.
Veranex submitted two abstracts from this study – one to the American Academy of Ophthalmology (AAO) 2020 Conference (28% acceptance rate for posters) and another to the International Society for Pharmacoeconomics and Outcomes Research, Europe (ISPOR-EU) 2020 Conference. Both were accepted as poster presentations. The ISPOR abstract, titled, Time Efficiencies Associated with an Innovative Optical Biometer in Cataract Surgery Planning- A Time-and-Motion Study, can be found here, and will be published in the upcoming Value in Health Journal (December 2020 Issue, Volume 23 and Issue S2).
Please do not hesitate to contact us to see how we can support your team.
4 min read
Bob Bouthillier Director, Electrical Engineering, Veranex We live in a time where we have easy access to biometrics that help both...
Companies preparing for an early phase study must deal with an array of challenges and decisions for biometrics, pharmacovigilance and regulatory...
2 min read
In this installment of our “Meet the Team” blog series, we talk to Soma Sekhar Koramatla, Associate Manager, Statistical Programming, Biometrics...